Algerian prostate cancer study seeks 2,000 men

NCT ID NCT07484971

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to describe the characteristics of prostate cancer in Algeria, including patient demographics, symptoms, diagnosis methods, and treatments. Researchers will collect data from 2,000 men aged 19 and older with confirmed prostate cancer. The goal is to better understand how prostate cancer is managed in Algeria, but this study does not test any new treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CAC Adrar - Oncology Department

    NOT_YET_RECRUITING

    Adrar, Algeria, 01000, Algeria

    Contact Email: •••••@•••••

  • CAC Adrar - Radiotherapy Department

    NOT_YET_RECRUITING

    Adrar, Algeria, 01000, Algeria

    Contact Email: •••••@•••••

  • CAC Annaba - Oncology Departement

    RECRUITING

    Annaba, Algeria, 23000, Algeria

    Contact Email: •••••@•••••

  • CAC Annaba - Radiotherapy Department

    RECRUITING

    Annaba, Algeria, 23000, Algeria

    Contact Email: •••••@•••••

  • CAC Annaba - Urology Departement

    RECRUITING

    Annaba, Algeria, 23000, Algeria

    Contact Email: •••••@•••••

  • CAC BLIDA - Oncology Department

    RECRUITING

    Algiers, Algeria, 16000, Algeria

    Contact Email: •••••@•••••

  • CAC BLIDA - Urology Department

    RECRUITING

    Blida, Algeria, 09000, Algeria

    Contact Email: •••••@•••••

  • CAC Bida - Radiotherapy Department

    RECRUITING

    Blida, Algeria, 09000, Algeria

    Contact Email: •••••@•••••

  • CAC Draa Ben Khedda - Radiotherapy Departement

    RECRUITING

    Tizi Ouzou, Algeria, 15000, Algeria

    Contact Email: •••••@•••••

  • CAC ORAN - Oncology Department

    RECRUITING

    Oran, Algeria, 31000, Algeria

    Contact Email: •••••@•••••

  • CAC ORAN - Radiotherapy Department

    RECRUITING

    Oran, Algeria, 31000, Algeria

    Contact Email: •••••@•••••

  • CAC Sétif - Oncology Departement

    RECRUITING

    Sétif, Algeria, 19000, Algeria

    Contact Email: •••••@•••••

  • CAC Sétif - Radiotherapy Department

    RECRUITING

    Sétif, Algeria, 19000, Algeria

    Contact Email: •••••@•••••

  • CHU Bab El Oued

    RECRUITING

    Algiers, Algeria, 16000, Algeria

    Contact Email: •••••@•••••

  • CHU Béni Messous - Oncology Departement

    RECRUITING

    Algiers, Algeria, 16000, Algeria

    Contact Email: •••••@•••••

  • CHU Constantine - Oncology Departement

    RECRUITING

    Constantine, Algeria, 25000, Algeria

    Contact Email: •••••@•••••

  • Centre Pierre et Marie Curie - Oncology Department

    RECRUITING

    Algiers, Algeria, 16000, Algeria

    Contact Email: •••••@•••••

  • Centre Pierre et Marie Curie - Radiology Department

    RECRUITING

    Algiers, Algeria, 16000, Algeria

    Contact Email: •••••@•••••

  • EH Constantine - Oncology Departement

    RECRUITING

    Constantine, Algeria, 25000, Algeria

    Contact Email: •••••@•••••

  • EHU ORAN - Oncology Department

    NOT_YET_RECRUITING

    Oran, Algeria, 31000, Algeria

    Contact Email: •••••@•••••

  • EHU ORAN - Urology Department

    RECRUITING

    Oran, Algeria, 31000, Algeria

    Contact Email: •••••@•••••

  • EPH Mostaghanem - Oncology Department

    RECRUITING

    Mostaganem, Algeria, 27000, Algeria

    Contact Email: •••••@•••••

  • EPH ROUIBA - Oncology Department

    RECRUITING

    Algiers, Algeria, 16000, Algeria

    Contact Email: •••••@•••••

  • EPH Sidi Ghilès - Oncology Department

    RECRUITING

    Tipasa, Algeria, 42000, Algeria

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.